Monday is Fasting Day - Non-Randomized Trial on Intermittent Fasting
NCT ID: NCT02253056
Last Updated: 2015-03-31
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
36 participants
INTERVENTIONAL
2014-09-30
2015-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Participants in the control group receive an initial group training for healthy diet according to current German guidelines (DGE). Moreover, they will receive the same offer as in the intervention group at the end of the 8-week study period. Until then the control group participants follow a regular healthy diet.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Fasting
Intermittent fasting over 8 weeks (one day per week)
Fasting / Caloric Restriction
Healthy diet
Regular healthy diet according to current German (DGE) guidelines for healthy nutrition.
Healthy Diet
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Fasting / Caloric Restriction
Healthy Diet
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* written informed consent
Exclusion Criteria
* eating disorders
* pregnancy
* planed pregnancy
* simultaneous participation in other trials
18 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Immanuel Hospital, Berlin, Germany
UNKNOWN
Charite University, Berlin, Germany
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Andreas Michalsen
Prof. Dr. med. Andreas Michalsen
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Andreas Michalsen, MD
Role: PRINCIPAL_INVESTIGATOR
Charité Medical University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Immanuel Hospital Berlin
Berlin, State of Berlin, Germany
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
Research Institute´s Homepage
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MIFT-Trial
Identifier Type: -
Identifier Source: org_study_id